DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies

Author： Fahy Jacques Jeltsch Albert Arimondo Paola B

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.12, 2012-12, pp. : 1427-1442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetic cancer therapies: DNA methyltransferase inhibitors

By Brown Robert Strathdee Gordon

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 747-754

Informa Healthcare

Access to resources Recommend Favorite

DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-05 ,pp. : 379-399

Bentham Science Publishers

Access to resources Recommend Favorite

DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences

By Thomas Xavier

Expert Opinion on Drug Discovery, Vol. 7, Iss. 11, 2012-11 ,pp. : 1039-1051

Informa Healthcare

Access to resources Recommend Favorite

Quorum sensing inhibitors: a patent overview

By Pan Jiachuan Ren Dacheng

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 11, 2009-11 ,pp. : 1581-1601

Informa Healthcare

Access to resources Recommend Favorite

Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases

Current Medicinal Chemistry, Vol. 16, Iss. 17, 2009-06 ,pp. : 2075-2085

Bentham Science Publishers

Access to resources Recommend Favorite